| [1] | IMAI A,KOMATSU S,OHARA T,et al.Serum cystatin C is associated with early stage coronary atherosclerotic plaque morphology on multidetector computed tomography[J].Atherosclerosis,2011,218(2):350. |
| [2] | WOITAS RP,KLEBER ME,MEINITZER A,et al.Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronaryangiography.The Ludwigshafen Risk and Cardiovascular Health(LURIC)study[J].Atherosclerosis,2013,229(2):541. |
| [3] | GENSINI GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(3):606. |
| [4] | 刘承荣,张晓刚.胱抑素C与心血管疾病的关系[J].现代医药卫生,2015,31(19):2931. |
| [5] | ANGELIDIS C,DEFTEREOS S,GIANNOPOULOS G,et al.Cystatin C:an emerging biomarker in cardiovascular disease[J].Curr Top Med Chem,2013,13(2):164. |
| [6] | 陈湘桂,仇昌智,刘醒存.冠心病病人不同胱抑素C和同型半胱氨酸与冠状动脉病变的相关性临床[J].心血管病杂志,2009,25(8):609. |
| [7] | 王蒙蒙,李恩,汪涛.冠心病病人胱抑素C及糖化血红蛋白水平与冠脉病变的关系[J].实用医学杂志,2015,31(22):3704. |
| [8] | TAGLIERI N,KOENIG W,KASKI JC.Cystatin C and cardiovascular risk[J].Clin Chem,2009,55(11):1932. |
| [9] | NOTO D,CEFALU AB,BARBAGALLO CM,et al.Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J].Int J Cardiol,2005,101(2):213. |
| [10] | LUO J,WANG LP,HU HF,et al.Cystatin C and cardiovascular or all-cause mortality risk in the general population:A meta-analysis[J].Clin Chim Acta,2015,450:39. |
| [11] | ZHAO R,LI Y,DAI W.Serum Cystatin C and the Risk of Coronary Heart Disease in Ethnic Chinese Patients With Normal Renal Function[J].Lab Med,2016,47(1):13. |